Pathogenicity of Mycobacterium tuberculosis Is Expressed by Regulating Metabolic Thresholds of the Host Macrophage

PLoS Pathogens

Volumn 10, Issue 7, 2014, Pages

  Mehrotra, Parul ^a   Jamwal, Shilpa V ^a   Saquib, Najmuddin ^a   Sinha, Neeraj ^a   Siddiqui, Zaved ^a   Manivel, Venkatasamy ^a   Chatterjee, Samrat ^a   Rao, Kanury V S ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; VIRULENCE FACTOR;

ANIMAL; BAGG ALBINO MOUSE; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MACROPHAGE; METABOLISM; MICROBIOLOGY; MOLECULAR GENETICS; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NUCLEOTIDE SEQUENCE; PATHOGENICITY; PATHOLOGY; TUBERCULOSIS;

ANIMALS; BACTERIAL PROTEINS; BASE SEQUENCE; FEMALE; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; MACROPHAGES; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS; VIRULENCE FACTORS;

EID: 84905367555     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1004265     Document Type: Article

References (59)

1. de Carvalho LPS, Fischer SM, Marrero J, Nathan C, Ehrt S, et al. (2010) Metabolomics of Mycobacterium tuberculosis Reveals Compartmentalized Co-Catabolism of Carbon Substrates. Chemistry & biology 17: 1122-1131.
2. Daniel J, Maamar H, Deb C, Sirakova TD, Kolattukudy PE, (2011) Mycobacterium tuberculosis uses host triacylglycerol to accumulate lipid droplets and acquires a dormancy-like phenotype in lipid-loaded macrophages. PLoS pathogens 7: e1002093.
3. Muñoz-Elías EJ, McKinney JD, (2005) Mycobacterium tuberculosis isocitrate lyases 1 and 2 are jointly required for in vivo growth and virulence. Nature medicine 11: 638-644.
4. Pandey AK, Sassetti CM, (2008) Mycobacterial persistence requires the utilization of host cholesterol. Proceedings of the National Academy of Sciences 105: 4376-4380.
5. Rohde KH, Veiga DF, Caldwell S, Balázsi G, Russell DG, (2012) Linking the transcriptional profiles and the physiological states of Mycobacterium tuberculosis during an extended intracellular infection. PLoS pathogens 8: e1002769.
6. Russell DG, Barry CE, Flynn JL, (2010) Tuberculosis: what we don't know can, and does, hurt us. Science 328: 852-856.
7. Russell DG, Cardona P-J, Kim M-J, Allain S, Altare F, (2009) Foamy macrophages and the progression of the human tuberculosis granuloma. Nature immunology 10: 943-948.
8. Russell DG, VanderVen BC, Lee W, Abramovitch RB, Kim M-j, et al. (2010) Mycobacterium tuberculosis Wears What It Eats. Cell host & microbe 8: 68-76.
9. Sauer U, (2006) Metabolic networks in motion: 13C-based flux analysis. Molecular systems biology 2: 62.
10. Yuan J, Bennett BD, Rabinowitz JD, (2008) Kinetic flux profiling for quantitation of cellular metabolic fluxes. Nature protocols 3: 1328-1340.
11. Yuan J, Fowler WU, Kimball E, Lu W, Rabinowitz JD, (2006) Kinetic flux profiling of nitrogen assimilation in Escherichia coli. Nature chemical biology 2: 529-530.
12. Curi R, Newsholme P, Pithon-Curi T, Pires-de-Melo M, Garcia C, et al. (1999) Metabolic fate of glutamine in lymphocytes, macrophages and neutrophils. Brazilian Journal of Medical and Biological Research 32: 15-21.
13. Singh V, Jamwal S, Jain R, Verma P, Gokhale R, et al. (2012) Mycobacterium tuberculosis-Driven Targeted Recalibration of Macrophage Lipid Homeostasis Promotes the Foamy Phenotype. Cell host & microbe 12: 669-681.
14. Ihrlund LS, Hernlund E, Khan O, Shoshan MC, (2008) 3-Bromopyruvate as inhibitor of tumour cell energy metabolism and chemopotentiator of platinum drugs. Molecular oncology 2: 94-101.
15. Pereira DSA, El-Bacha T, Kyaw N, Dos Santos R, Da-Silva W, et al. (2009) Inhibition of energy-producing pathways of HepG2 cells by 3-bromopyruvate1. Biochem J 417: 717-726.
16. Resat H, Petzold L, Pettigrew MF (2009) Kinetic modeling of biological systems. Computational Systems Biology:Springer. pp. 311-335.
17. Kumar D, Nath L, Kamal MA, Varshney A, Jain A, et al. (2010) Genome-wide Analysis of the Host Intracellular Network that Regulates Survival of Mycobacterium tuberculosis. Cell 140: 731-743.
18. Barghouthi S, Everett K, Speert DP, (1995) Nonopsonic phagocytosis of Pseudomonas aeruginosa requires facilitated transport of D-glucose by macrophages. The Journal of Immunology 154: 3420-3428.
19. Ida-Yonemochi H, Nakatomi M, Harada H, Takata H, Baba O, et al. (2012) Glucose uptake mediated by glucose transporter 1 is essential for early tooth morphogenesis and size determination of murine molars. Developmental biology 363: 52-61.
20. Rodríguez-Enríquez S, Marín-Hernández A, Gallardo-Pérez JC, Moreno-Sánchez R, (2009) Kinetics of transport and phosphorylation of glucose in cancer cells. Journal of cellular physiology 221: 552-559.
21. Siess EA, Kientsch-Engel RI, Wieland OH, (1982) Role of free oxaloacetate in ketogenesis. European Journal of Biochemistry 121: 493-499.
22. Segal W, Bloch H, (1956) Biochemical differentiation of Mycobacterium tuberculosis grown in vivo and in vitro. Journal of bacteriology 72: 132.
23. Lee W, VanderVen BC, Fahey RJ, Russell DG, (2013) Intracellular Mycobacterium tuberculosis exploits host-derived fatty acids to limit metabolic stress. Journal of Biological Chemistry 288: 6788-6800.
24. Farese Jr RV, Walther TC, (2009) Lipid droplets finally get a little RESPECT. Cell 139: 855-860.
25. D'Avila H, Melo RC, Parreira GG, Werneck-Barroso E, Castro-Faria-Neto HC, et al. (2006) Mycobacterium bovis bacillus Calmette-Guerin induces TLR2-mediated formation of lipid bodies: intracellular domains for eicosanoid synthesis in vivo. The Journal of Immunology 176: 3087-3097.
26. Peyron P, Vaubourgeix J, Poquet Y, Levillain F, Botanch C, et al. (2008) Foamy macrophages from tuberculous patients' granulomas constitute a nutrient-rich reservoir for M. tuberculosis persistence. PLoS pathogens 4: e1000204.
27. Thiam AR, Farese Jr RV, Walther TC, (2013) The biophysics and cell biology of lipid droplets. Nature Reviews Molecular Cell Biology 14: 775-786.
28. Llaverias G, Lacasa D, Viñals M, Vázquez-Carrera M, Sánchez RM, et al. (2004) Reduction of intracellular cholesterol accumulation in THP-1 macrophages by a combination of rosiglitazone and atorvastatin. Biochemical pharmacology 68: 155-163.
29. Gao Y, Lin L-P, Zhu C-H, Chen Y, Hou Y-T, et al. (2006) Research Paper Growth Arrest Induced by C75, A Fatty Acid Synthase Inhibitor, was Partially Modulated by p38 MAPK but Not by p53 In Human Hepatocellular Carcinoma. Cancer biology & therapy 5: 978-985.
30. Kim MJ, Wainwright HC, Locketz M, Bekker LG, Walther GB, et al. (2010) Caseation of human tuberculosis granulomas correlates with elevated host lipid metabolism. EMBO molecular medicine 2: 258-274.
31. Aronis A, Madar Z, Tirosh O, (2005) Mechanism underlying oxidative stress-mediated lipotoxicity: exposure of J774. 2 macrophages to triacylglycerols facilitates mitochondrial reactive oxygen species production and cellular necrosis. Free Radical Biology and Medicine 38: 1221-1230.
32. Aronis A, Madar Z, Tirosh O, (2008) Lipotoxic effects of triacylglycerols in J774. 2 macrophages. Nutrition 24: 167-176.
33. Brasaemle DL, Rubin B, Harten IA, Gruia-Gray J, Kimmel AR, et al. (2000) Perilipin A increases triacylglycerol storage by decreasing the rate of triacylglycerol hydrolysis. Journal of Biological Chemistry 275: 38486-38493.
34. Halestrap AP, (1978) Pyruvate and ketone-body transport across the mitochondrial membrane. Exchange properties, pH-dependence and mechanism of the carrier. Biochem J 172: 377-387.
35. Herzig S, Raemy E, Montessuit S, Veuthey J-L, Zamboni N, et al. (2012) Identification and functional expression of the mitochondrial pyruvate carrier. Science 337: 93-96.
36. Behar SM, Divangahi M, Remold HG, (2010) Evasion of innate immunity by Mycobacterium tuberculosis: is death an exit strategy? Nature Reviews Microbiology 8: 668-674.
37. Fratazzi C, Arbeit RD, Carini C, Remold HG, (1997) Programmed cell death of Mycobacterium avium serovar 4-infected human macrophages prevents the mycobacteria from spreading and induces mycobacterial growth inhibition by freshly added, uninfected macrophages. The Journal of Immunology 158: 4320-4327.
38. Lee J, Hartman M, Kornfeld H, (2009) Macrophage apoptosis in tuberculosis. Yonsei medical journal 50: 1-11.
39. López M, Sly LM, Luu Y, Young D, Cooper H, et al. (2003) The 19-kDa Mycobacterium tuberculosis protein induces macrophage apoptosis through Toll-like receptor-2. The Journal of Immunology 170: 2409-2416.
40. Oddo M, Renno T, Attinger A, Bakker T, MacDonald HR, et al. (1998) Fas ligand-induced apoptosis of infected human macrophages reduces the viability of intracellular Mycobacterium tuberculosis. The Journal of Immunology 160: 5448-5454.
41. Lee J, Repasy T, Papavinasasundaram K, Sassetti C, Kornfeld H, (2011) Mycobacterium tuberculosis induces an atypical cell death mode to escape from infected macrophages. PloS one 6: e18367.
42. Ramakrishnan L, (2012) Revisiting the role of the granuloma in tuberculosis. Nature Reviews Immunology 12: 352-366.
43. Thi EP, Lambertz U, Reiner NE, (2012) Sleeping with the enemy: how intracellular pathogens cope with a macrophage lifestyle. PLoS pathogens 8: e1002551.
44. Baker MA, Harries AD, Jeon CY, Hart JE, Kapur A, et al. (2011) The impact of diabetes on tuberculosis treatment outcomes: a systematic review. BMC medicine 9: 81.
45. Dooley KE, Chaisson RE, (2009) Tuberculosis and diabetes mellitus: convergence of two epidemics. The Lancet infectious diseases 9: 737-746.
46. Jeon CY, Murray MB, (2008) Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS medicine 5: e152.
47. Martens GW, Arikan MC, Lee J, Ren F, Greiner D, et al. (2007) Tuberculosis susceptibility of diabetic mice. American journal of respiratory cell and molecular biology 37: 518.
48. Vallerskog T, Martens GW, Kornfeld H, (2010) Diabetic mice display a delayed adaptive immune response to Mycobacterium tuberculosis. The Journal of Immunology 184: 6275-6282.
49. Xavier MN, Winter MG, Spees AM, den Hartigh AB, Nguyen K, et al. (2013) PPARγ-Mediated Increase in Glucose Availability Sustains Chronic Brucella abortus Infection in Alternatively Activated Macrophages. Cell host & microbe 14: 159-170.
50. Pezzulo AA, Gutiérrez J, Duschner KS, McConnell KS, Taft PJ, et al. (2011) Glucose depletion in the airway surface liquid is essential for sterility of the airways. PloS one 6: e16166.
51. Lin J, Li H, Yang M, Ren J, Huang Z, et al. (2013) A role of RIP3-mediated macrophage necrosis in atherosclerosis development. Cell reports 3: 200-210.
52. Moore KJ, Tabas I, (2011) Macrophages in the pathogenesis of atherosclerosis. Cell 145: 341-355.
53. Rota S, Rota S, (2005) c yb o osis acterium tubercul M. Acta Med Okayama 59: 247-251.
54. Sheu J-J, Chiou H-Y, Kang J-H, Chen Y-H, Lin H-C, (2010) Tuberculosis and the Risk of Ischemic Stroke A 3-Year Follow-Up Study. Stroke 41: 244-249.
55. Tabas I, (1997) Free cholesterol-induced cytotoxicity: a possible contributing factor to macrophage foam cell necrosis in advanced atherosclerotic lesions. Trends in cardiovascular medicine 7: 256-263.
56. Munger J, Bennett BD, Parikh A, Feng X-J, McArdle J, et al. (2008) Systems-level metabolic flux profiling identifies fatty acid synthesis as a target for antiviral therapy. Nature biotechnology 26: 1179-1186.
57. Guay C, Madiraju SM, Aumais A, Joly É, Prentki M, (2007) A role for ATP-citrate lyase, malic enzyme, and pyruvate/citrate cycling in glucose-induced insulin secretion. Journal of Biological Chemistry 282: 35657-35665.
58. Li JJ, Wang H, Tino JA, Robl JA, Herpin TF, et al. (2007) 2-Hydroxy-N-arylbenzenesulfonamides as ATP-citrate lyase inhibitors. Bioorganic & medicinal chemistry letters 17: 3208-3211.
59. Huang C, Kuo W, Huang Y, Lee T, Yu L, (2013) Resistance to hypoxia-induced necroptosis is conferred by glycolytic pyruvate scavenging of mitochondrial superoxide in colorectal cancer cells. Cell death & disease 4: e622.